Velsera

Velsera, founded in 2023 by Seven Bridges and Pierian, accelerates life-changing insights in precision medicine through integrated software and professional services. The company specializes in multimodal data harmonization and analytics for drug discovery and development, in vitro diagnostic (IVD) development, validation, and regulatory approval, and clinical next-generation sequencing (NGS) interpretation, reporting, and adoption. By combining advanced analytics with a robust platform, Velsera streamlines the translation of complex biomedical data into actionable clinical and regulatory outcomes. Its collaborative foundation and community-centric approach position it as a distinctive partner for pharmaceutical, biotech, and diagnostic companies seeking to accelerate innovation and improve patient outcomes.